EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

GPs’ perspectives on GLP-1RAs for obesity management: a qualitative study in England

Sabrina Keating iD, Cervantée Wild iD, Jadine Scragg, Sharon Dixon iD, Julian Treadwell iD, Lisa Hinton iD, Susan Ann Jebb iD

British Journal of General Practice · 01.11.2025 · 75 (760) · e759-e767

DOI: 10.3399/bjgp.2025.0065 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift British Journal of General Practice, online erschienen am 08.07.2025. Verfasst von Sabrina Keating und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Primary Care Building, Oxford, UK. Hauptthemen laut MEDLINE: Obesity, Attitude of Health Personnel, Glucagon-Like Peptide-1 Receptor Agonists, General Practitioners. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Effective treatments are needed for the increasing number of people living with obesity. GPs are key in managing obesity within the NHS but report low confidence in available treatment options. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown promise in weight management, but at the time of this study lacked commissioned primary care service pathways for this indication.

Aim

To explore the perspectives of NHS GPs in England on GLP-1RAs and their integration into primary care for weight management. Design and setting In this qualitative study, participants were GPs practising in England, recruited through purposive sampling to reflect diverse geographical and socioeconomic contexts.

Method

Twenty-five semi-structured interviews, which were conducted April–July 2024, were thematically analysed.

Results

Participants generally held positive views about the implementation of GLP-1RAs for weight management in primary care; however, this was joined by hesitations about resource limitations. Navigating consultations with patients asking for prescriptions, or support with private use, often posed difficulties. Concerns included that GLP-1RAs could detract from tackling the broader determinants of obesity. Participants also worried that the medications could be misused, ultimately becoming an overly simplistic solution for patients, practitioners, and the wider health system.

Conclusion

Our findings suggest that while GPs view GLP-1RA integration as a valuable therapeutic option for primary care obesity management, they have concerns about this being done well. To strengthen GP support for implementation, it is essential to recognise the need for adequate resources and ensure that GLP-1RAs are integrated into a holistic strategy for addressing obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityAttitude of Health PersonnelGlucagon-Like Peptide-1 Receptor AgonistsGeneral PractitionersObesity ManagementHumansEnglandQualitative ResearchMaleFemalePrimary Health CareMiddle AgedState MedicineAdultPractice Patterns, Physicians'

Stichwörter der Autor:innen

general practiceglucagon-like peptide 1glucagon-like peptide-1 receptor agonistsobesity managementqualitative research

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Primary Care Building, Oxford, UK.
  • The University of Auckland Department of Paediatrics Child and Youth Health, Auckland, New Zealand.
  • University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Primary Care Building, Oxford, UK jadine.scragg@phc.ox.ac.uk.
  • NIHR doctoral research fellow and general practitioner, Donnington Medical Partnership, Oxford, UK.
  • NIHR academic clinical lecturer, University of Bristol, Bristol Medical School (PHS), Bristol, UK.

ORCID-Profile: Sabrina Keating, Cervantée Wild, Sharon Dixon, Julian Treadwell, Lisa Hinton, Susan Ann Jebb

Zitieren

APA

Keating, S., Wild, C., Scragg, J., Dixon, S., Treadwell, J., Hinton, L., & Jebb, S. A. (2025). GPs’ perspectives on GLP-1RAs for obesity management: a qualitative study in England. British Journal of General Practice, 75(760), e759-e767. https://doi.org/10.3399/bjgp.2025.0065

Vancouver

Keating S, Wild C, Scragg J, Dixon S, Treadwell J, Hinton L, et al. GPs’ perspectives on GLP-1RAs for obesity management: a qualitative study in England. British Journal of General Practice. 2025;75(760):e759-e767. doi:10.3399/bjgp.2025.0065

BibTeX
@article{Keating2025,
  author = {Keating, Sabrina and Wild, Cervantée and Scragg, Jadine and Dixon, Sharon and Treadwell, Julian and Hinton, Lisa and Jebb, Susan Ann},
  title = {GPs’ perspectives on GLP-1RAs for obesity management: a qualitative study in England},
  journal = {British Journal of General Practice},
  year = {2025},
  volume = {75},
  number = {760},
  pages = {e759--e767},
  doi = {10.3399/bjgp.2025.0065}
}
Kostenlos starten →